Press Releases

Year

22 Feb '23

Veradigm Announces Two New Appointments to Its Board

Pharmaceutical executive Susan Rodriguez and digital health/pharma services entrepreneur Dr. Shih-Yin Ho join Board of Directors CHICAGO --(BUSINESS WIRE)--Feb. 22, 2023-- Susan Rodriguez and Shih-Yin Ho , MD have been named to the Board of Directors of Veradigm Inc. (NASDAQ: MDRX).

PDF Version

21 Feb '23

Veradigm to Release Fourth Quarter and Fiscal Year 2022 Financial Results March 1

CHICAGO --(BUSINESS WIRE)--Feb. 21, 2023-- Veradigm ® , Inc. (NASDAQ: MDRX), will report its financial results for the three and twelve months ended December 31, 2022 after the close of the regular stock market hours on Wednesday, March 1, 2023 . Veradigm management plans to host a conference call

PDF Version

13 Feb '23

Veradigm and HealthVerity Collaborate to Advance Real-World Evidence and Care for Patients with Cardiovascular Disease and Diabetes

Veradigm Cardiology and Veradigm Metabolic Registry Data Now Available Through the HealthVerity IPGE Platform CHICAGO & PHILADELPHIA, February 13, 2023 --( BUSINESS WIRE )--Veradigm®, a leading provider of healthcare data and technology solutions (NASDAQ: MDRX), and HealthVerity®, a leader in

PDF Version

09 Feb '23

Veradigm FollowMyHealth Named Most Improved Software Product by KLAS

Veradigm FollowMyHealth customer satisfaction has improved more than any other software solution over the past year, strengthening patient care and experience CHICAGO --(BUSINESS WIRE)--Feb. 9, 2023-- Veradigm Inc. (NASDAQ: MDRX), announced today that Veradigm FollowMyHealth (formerly

PDF Version

30 Jan '23

Veradigm® Network EHR Data is Now Available in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) Format

New delivery format for three integrated electronic health record (EHR) sources to provide delivery flexibility for Veradigm clients CHICAGO --(BUSINESS WIRE)--Jan. 30, 2023-- Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format.

PDF Version

11 Jan '23

Veradigm Announces New Share Repurchase Program and Initial Financial Guidance for Fiscal 2023

CHICAGO --(BUSINESS WIRE)--Jan. 11, 2023-- Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc. , announced today that its Board of Directors has approved a new share repurchase program under which Veradigm may purchase up to $250 million of its common stock.

PDF Version

10 Jan '23

Veradigm Building Momentum Across All Markets

CHICAGO --(BUSINESS WIRE)--Jan. 10, 2023-- Veradigm Inc. (NASDAQ: MDRX) reports today strong fourth quarter new business results across all markets including the payer, life science, and provider markets. The Veradigm Payer business added 6 net-new regional and national payer clients in Q4,

PDF Version

09 Jan '23

Veradigm Announces Strategic Investment in Holmusk

This collaboration fuels the expansion of a leading source of real-world clinical behavioral health data CHICAGO --(BUSINESS WIRE)--Jan. 9, 2023-- Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc. , announced today an investment in Holmusk, a global behavioral health

PDF Version

06 Jan '23

Veradigm to Present at the 2023 J.P. Morgan Healthcare Conference

CHICAGO --(BUSINESS WIRE)--Jan. 6, 2023-- Veradigm Inc. (Nasdaq:MDRX), formerly Allscripts Healthcare Solutions Inc. , announced today that Rick Poulton , Veradigm Chief Executive Officer, will present at the 2023 J.P. Morgan Healthcare conference on Wednesday, January 11, 2023 at 3:45 PST .

PDF Version

03 Jan '23

Allscripts Announces Corporate Name Change to Veradigm Inc.

CHICAGO --(BUSINESS WIRE)--Jan. 3, 2023-- Allscripts Healthcare Solutions, Inc. announced today that, effective January 1, 2023 , it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand during 2022, and Allscripts will now

PDF Version

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Press Releases

Press Releases

Contact Investor Relations

Request E-mail Alerts